US Stocks
/
Trevi Therapeutics, Inc. Share Price
Trevi Therapeutics, Inc. Share Price

Trevi Therapeutics, Inc. Share Price

NASDAQ: TRVI | Small Cap
$13.15
-$0.04 (-0.3%) Last updated on 08 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Trevi Therapeutics, Inc. Stock Performance

Open
$12.92
Prev. Close
$13.19
Circuit Range
N/A
Day Range
$12.92 - $13.53
Year Range
$9.32 - $20.14
Volume
1,38,800
Average Traded
$13.32

Trevi Therapeutics, Inc. Share Price Today

As of 8 October 2026, Trevi Therapeutics, Inc.'s share price is $13.15. The stock opened at $12.92, compared to its previous close of $13.19. During today's trading session, Trevi Therapeutics, Inc.'s share price traded between $12.92 and $13.53, with an average price of $13.22. Over the past 52 weeks, the stock has recorded a high of $20.14 and a low of $9.32. In terms of performance, Trevi Therapeutics, Inc.'s share price has declined by 4.36% over the last six months and is up 12.83% on a year-on-year basis.

Trevi Therapeutics, Inc. Share Price Chart

$12.92$13.53
L
Show Current Price
H

Trevi Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$1.77B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.36
Revenue (TTM)
$0.00
Return On Equity (TTM)
-15.90%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-50.85%

Trevi Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$11.80-$8.32-$13.19-$17.80
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A29.49%-58.53%-34.95%

Trevi Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$29.15-$29.07-$47.91-$42.76
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A0.27%-64.81%10.75%

About Trevi Therapeutics, Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, non-IPF interstitial lung disease, or non-IPF ILD, and refractory chronic cough, or RCC. Haduvio is an oral extended-release formulation of nalbuphine. The Company operates and manages its business as one reportable segment. Such a segment is the business of developing and commercializing the investigational therapy Haduvio.

Trevi Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$14.30
$13.14
-8.04%
Sep 2026
$16.63
$14.29
-20.41%
Aug 2026
$17.99
$17.96
-1.64%
Jul 2026
$18.70
$18.26
-2.01%
Jun 2026
$13.88
$18.64
+31.79%
May 2026
$13.78
$14.14
+2.84%
Apr 2026
$11.98
$13.75
+15.26%
Mar 2026
$12.09
$11.93
+0.21%
Feb 2026
$10.51
$11.90
+13.65%
Jan 2026
$12.38
$10.47
-16.23%
Dec 2025
$13.13
$12.51
-5.12%
Nov 2025
$11.73
$13.18
+13.08%

TRVI Share Price FAQs

What is Trevi Therapeutics, Inc. share price today?

chevron-up
Trevi Therapeutics, Inc. share price today is $13.15 as on October 8, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Trevi Therapeutics, Inc. stock?

chevron-up
The 52 week high of Trevi Therapeutics, Inc. stock is $20.14, while the 52 week low is $9.32 as of 8 Oct '26.

What is TRVI's market capitalisation today?

chevron-up
TRVI market capitalisation is $1.77B as of October 8, 2026, at 4:09 pm IST.

What is TRVI's net income for the last quarter?

chevron-up
TRVI's net income for the last quarter is -17.80B USD.

What is the 5 year returns of TRVI?

chevron-up
The 5 year returns of TRVI is 1019.15% as on 8 Oct '26.

What is the high & low stock price of TRVI today?

chevron-up
TRVI stock price hit a high of $13.53 and low of $12.92 as of 8 Oct '26.

Can I buy TRVI shares in India?

chevron-up
Yes. You can buy TRVI in India by opening an international trading account.